- Home
- NVRI vs HUMA Comparison
NVRI vs HUMA Comparison
Compare NVRI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- HUMA
- Stock Information
- Founded
- NVRI 1853
- HUMA 2004
- Country
- NVRI United States
- HUMA United States
- Employees
- NVRI N/A
- HUMA N/A
- Industry
- NVRI Diversified Commercial Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- NVRI Miscellaneous
- HUMA Health Care
- Exchange
- NVRI Nasdaq
- HUMA Nasdaq
- Market Cap
- NVRI 521.3M
- HUMA 221.8M
- IPO Year
- NVRI N/A
- HUMA N/A
- Fundamental
- Price
- NVRI $7.11
- HUMA $1.21
- Analyst Decision
- NVRI Hold
- HUMA Strong Buy
- Analyst Count
- NVRI 1
- HUMA 6
- Target Price
- NVRI $10.00
- HUMA $14.60
- AVG Volume (30 Days)
- NVRI 697.5K
- HUMA 2.9M
- Earning Date
- NVRI 05-01-2025
- HUMA 05-20-2025
- Dividend Yield
- NVRI N/A
- HUMA N/A
- EPS Growth
- NVRI N/A
- HUMA N/A
- EPS
- NVRI N/A
- HUMA N/A
- Revenue
- NVRI $2,290,612,000.00
- HUMA N/A
- Revenue This Year
- NVRI N/A
- HUMA N/A
- Revenue Next Year
- NVRI $3.63
- HUMA $1,178.20
- P/E Ratio
- NVRI N/A
- HUMA N/A
- Revenue Growth
- NVRI N/A
- HUMA N/A
- 52 Week Low
- NVRI $4.72
- HUMA $1.15
- 52 Week High
- NVRI $12.79
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- NVRI 62.50
- HUMA 30.35
- Support Level
- NVRI $6.67
- HUMA $1.35
- Resistance Level
- NVRI $7.42
- HUMA $1.48
- Average True Range (ATR)
- NVRI 0.34
- HUMA 0.10
- MACD
- NVRI 0.11
- HUMA 0.03
- Stochastic Oscillator
- NVRI 81.58
- HUMA 4.26
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.